Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging

@article{Hofman2009ObserverVI,
  title={Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging},
  author={M. Hofman and N. Smeeton and S. Rankin and T. Nunan and M. O'Doherty},
  journal={Journal of Nuclear Medicine},
  year={2009},
  volume={50},
  pages={1594 - 1597}
}
Many studies demonstrate a high accuracy for PET in staging lymphoma, but few assess observer variation. This study quantified agreement for staging lymphoma with PET/CT. Methods: The PET/CT images of 100 patients with lymphoma who had been referred for staging were reviewed by 3 experienced observers, with 2 observers reviewing each series a second time. Ann Arbor stage and individual nodal and extranodal regions were assessed. Weighted κ (κw) and intraclass correlation coefficient were used… Expand
Computed Tomography Observer Agreement in Staging Malignant Lymphoma
TLDR
Computed tomography observer agreement in staging malignant lymphoma appears to be suboptimal, except for infraclavicular nodes. Expand
Intra- and inter-observer agreement in the visual interpretation of interim 18F-FDG PET/CT in malignant lymphoma: influence of clinical information
TLDR
The intra- and inter-observer agreements in evaluating interim PET/CT were relatively low for extranodal lesions, but they were substantial to almost perfect when interpreting nodal regions in malignant lymphoma, irrespective of the provision of clinical information. Expand
Current status of FDG-PET/CT in staging of adult lymphoma
TLDR
The updated guidance on the evaluation, staging and response assessment of patients affected by HL and NHL and on the use of PET/CT for staging and Response assessment suggest that a reasonable approach would be omit the standard full dose contrast-enhanced CT if not already performed, and perform a low-dose non-enhancing PET/ CT as a single imaging modality. Expand
Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis.
TLDR
F-18 FDG PET or PET/CT and MRI showed similar diagnostic performances for the detection of BMI in lymphoma patients, and further large multicenter studies would be necessary to substantiate the diagnostic accuracy. Expand
Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-centre read.
  • C. Furth, H. Amthauer, +9 authors C. Kobe
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2011
TLDR
The iPET interpretation assured low interobserver variability and high sensitivity for identification of pHL patients suffering relapse is achieved if [18F]-fluorodeoxyglucose uptake above the MBPS value is rated as a PET-positive finding. Expand
PET-CT and diagnostic CT: the synergy of metabolic and morphological data in onco-haematology.
TLDR
Interpretation of diagnostic CT in onco-haematology can be improved by combining it with an assessment of PET-CT, and the synergy between metabolic and morphological information leads to improved diagnostic capabilities and renders interpretations more reproducible. Expand
Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy
TLDR
PerCIST 1.0 provides a higher overall agreement between observers than the qualitative approach in categorizing early treatment response in NSCLC patients, and the inter-observer agreement is in fact strong when using PERCIST 2.0. Expand
Imaging in follicular NHL.
TLDR
There is strong data to support the use of FDG PET/CT for primary staging, resulting in significant management change, and molecular imaging is likely to play an increasing role in selection of patients for specific treatments and in prognostic stratification. Expand
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma
TLDR
Identification of fat necrosis in patients with a solitary FDG-avid nodule after therapy is important and may lead to the avoidance of unnecessary interventions or treatment, whilst follow-up imaging can be helpful as the metabolic abnormality regresses with time. Expand
In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy
TLDR
Assessment of BMI with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification in newly diagnosed DLBCL than does BMB. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 16 REFERENCES
Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma
TLDR
Amongst experienced reporters in a single centre, there was a very high level of agreement for both mediastinal nodal stage and detection of distant metastases with PET-CT, which supports the use ofPET-CT as a robust imaging modality for staging NSCLC. Expand
FDG PET in lymphoma: The need for standardization of interpretation. An observer variation study
TLDR
There are substantial disparities among nuclear medicine physicians' interpretations of FDG PET scans of lymphoma patients, which may affect patient care and results of multi-institutional clinical trials. Expand
Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography.
TLDR
There are disparities among radiologists' interpretations of cervical-thoracic CT imaging of patients with Hodgkin's disease and it is proposed that a standardized method of reporting might improve the consistency of interpretation of CT scans in these patients. Expand
Bilateral Hilar Foci on 18F-FDG PET Scan in Patients Without Lung Cancer: Variables Associated with Benign and Malignant Etiology
TLDR
In patients with nonlung cancer, in particular colorectal, foci of symmetric and mild uptake limited to the hilar regions that are stable on 2 sequential PET studies despite intervening anticancer therapy are likely related to a benign etiology. Expand
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.
PURPOSE To develop guidelines for performing and interpreting positron emission tomography (PET) imaging for treatment assessment in patients with lymphoma both in clinical practice and in clinicalExpand
The role of FDG PET in the management of lymphoma: what is the evidence base?
TLDR
This review evaluates the current level of confidence in the use of PET technology in initial staging, the assessment of early response to chemotherapy, the Assessment of residual masses at completion of initial treatment, follow-up, and radiotherapy planning. Expand
Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging
In the last decade, PET-only systems have been phased out and replaced with PET-CT systems. This merger of a functional and anatomical imaging modality turned out to be extremely useful in clinicalExpand
Radiology's Achilles' heel: error and variation in the interpretation of the Röntgen image.
  • P. Robinson
  • Medicine
  • The British journal of radiology
  • 1997
TLDR
Current developments show that where image features can be comprehensively described, computer analysis can replace the perception function of the observer, whilst the function of interpretation can in some cases be performed better by artificial neural networks. Expand
AJCC Cancer Staging Manual
TLDR
Purposes and Principles of Cancer Staging and End-Results Reporting are explained. Expand
A reappraisal of the kappa coefficient.
TLDR
It is concluded that under certain circumstances kappa can be interpreted as an indicator of validity, i.e. unbiasedness of the odds ratio, rather than simply as one of reliability. Expand
...
1
2
...